maintenance olaparib in patients with ovarian cancer
Published 7 years ago • 476 plays • Length 2:07Download video MP4
Download video MP3
Similar videos
-
0:40
dr. willmott on fda approval of maintenance olaparib in ovarian cancer
-
2:00
dr. zakashansky on the benefit of maintenance olaparib in brca ovarian cancer
-
1:25
dr. zakashansky on solo2 with maintenance olaparib in relapsed brca1/2 ovarian cancer
-
2:18
#esmo21 highlights on maintenance olaparib in ovarian cancer previously treated with parpi
-
11:22
olaparib in ovarian cancer
-
2:21
dr. rafii discusses clinical outcomes with olaparib in patients with ovarian cancer
-
6:03
olaparib maintenance for recurrent ovarian cancer
-
1:38
dr. liu on cediranib/olaparib in recurrent ovarian cancer
-
3:37
selecting patients to be treated with maintenance olaparib in the paola-1 trial
-
10:34
solo1: maintenance olaparib in advanced brca ovarian cancer
-
5:25
solo-1: frontline olaparib maintenance therapy in ovarian cancer
-
26:02
updates in ovarian cancer: frontline maintenance
-
6:18
value of olaparib in brca-mutated advanced ovarian cancer
-
3:56
solo1 trial of maintenance olaparib in advanced ovarian cancer | susana banerjee
-
1:20
dr. ledermann discusses olaparib in ovarian cancer
-
1:57
7-year os from solo1: sustained benefit with maintenance olaparib
-
1:49
dr. chon on challenges with maintenance therapy in ovarian cancer
-
8:26
the impact of paola-1 on frontline treatment of ovarian cancer
-
7:56
maintenance therapy in ovarian cancer